Department of Internal Medicine, Division of Angiology, Medical University Graz, Auenbruggerplatz 15, 8036 Graz, Austria.
Atherosclerosis. 2012 Dec;225(2):517-20. doi: 10.1016/j.atherosclerosis.2012.10.025. Epub 2012 Oct 11.
The CHA(2)DS(2)-VASc (congestive heart failure, hypertension, age ≥ 75 years (doubled), type 2 diabetes, previous stroke, transient ischemic attack, or thromboembolism (doubled), vascular disease, age 65-75 years, and sex category) score was published as a predictive scoring model for stroke in atrial fibrillation patients. As multiple vascular risk factors are included in this score we evaluated the occurrence of critical limb ischemia (CLI) in peripheral arterial occlusive disease (PAOD) patients according to their CHA(2)DS(2)-VASc score independent of a coexisting atrial fibrillation.
We evaluated 2237 PAOD patients treated at our institution from 2005 to 2010. CHA(2)DS(2)-VASc score was calculated and the occurrence of CLI was investigated. Furthermore all constituents of the score were investigated concerning association with CLI.
Frequency of CLI was higher in patients with a high CHA(2)DS(2)-VASc score. Age ≥ 75 years was associated with an increased risk for CLI (OR 3.0), as was age 65-75 years (OR 1.8), type 2 diabetes (OR 2.8), and the factor previous stroke, transient ischemic attack, or thromboembolism (OR 1.4). The occurrence of arterial hypertension was protective for CLI (OR 0.6). Sex and congestive heart failure were not associated with an increased CLI risk.
High CHA(2)DS(2)-VASc score is associated with a high CLI risk. As not all constituents are equally associated with CLI and some are even protective, a new score including only some of the factors should be evaluated for the prediction of CLI.
CHA(2)DS(2)-VASc(充血性心力衰竭、高血压、年龄≥75 岁(加倍)、2 型糖尿病、既往卒中、短暂性脑缺血发作或血栓栓塞(加倍)、血管疾病、65-75 岁和性别类别)评分被公布为预测房颤患者中风的评分模型。由于该评分包含多个血管危险因素,因此我们评估了外周动脉闭塞性疾病(PAOD)患者根据其 CHA(2)DS(2)-VASc 评分发生严重肢体缺血(CLI)的情况,而不考虑同时存在的房颤。
我们评估了 2005 年至 2010 年在我们机构治疗的 2237 例 PAOD 患者。计算了 CHA(2)DS(2)-VASc 评分,并研究了 CLI 的发生情况。此外,还研究了评分的所有成分与 CLI 的关系。
CHA(2)DS(2)-VASc 评分高的患者 CLI 发生率较高。年龄≥75 岁与 CLI 风险增加相关(OR 3.0),65-75 岁年龄(OR 1.8)、2 型糖尿病(OR 2.8)和既往卒中、短暂性脑缺血发作或血栓栓塞(OR 1.4)也是如此。动脉高血压的发生对 CLI 有保护作用(OR 0.6)。性别和充血性心力衰竭与 CLI 风险增加无关。
高 CHA(2)DS(2)-VASc 评分与 CLI 风险增加相关。由于并非所有成分都与 CLI 同等相关,有些成分甚至具有保护作用,因此应该评估仅包括部分因素的新评分以预测 CLI。